Properties of testosterone transdermal gel in restoring serum testosterone levels in critically ill patients: the TestICU-1 pilot study

J Crit CarePublished Randomised controlled trial

Authors' conclusion

The administration of T-gel did not increase significantly the percentage of patients with normal serum T values as compared to control.

Study context

Population
Intensive care unit (ICU) patients receiving vasopressors and mechanical ventilation for at least 2 days; excluding prostate or breast cancer, PSA >4 ng/mL, age ≥ 80 years19 (63 %) men
Participants
30 patients
Comparison
Testosterone transdermal gel for 14 days vs control
Primary endpoint
Percentage of patients with serum Total T value within normal ranges
Follow-up
Days 4, 7, 10 and 14
Methodological detailsopen, monocentric, pilot
  • Open
  • Monocentric
  • Pilot

Primary result

As reported in the abstract

  • Percentage of patients with normal serum Total T did not differ between T and controls

Further findings

Serum Total T within normal range at inclusion

None of the men and half of the women within normal range

Safety

Cardiovascular events and cytolysis

No significant differences between groups

Original publication

Properties of testosterone transdermal gel in restoring serum testosterone levels in critically ill patients: the TestICU-1 pilot study. J Crit Care. Published 15 November 2025. doi:10.1016/j.jcrc.2025.155339

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.